Ctrl

K

Table of contents

Expand All Topics

Keloids and hypertrophic scars

Background

Overview

Definition
Keloids and hypertrophic scars are cutaneous fibroproliferative disorders resulting from abnormal wound healing, characterized by excessive collagen deposition. In keloids, abnormal proliferation of the dermal layer extends beyond the original wound borders, while in hypertrophic scars, it remains within the original wound boundaries.
1
Pathophysiology
The pathogenesis of keloids and hypertrophic scars is not fully understood but involves dysregulation of wound healing phases, excessive fibroblast activity, and collagen deposition. Injury to the reticular dermis from surgery, burns, or trauma is a key trigger, while minor injuries like folliculitis or insect bites can induce keloids in susceptible individuals. Hypertrophic scars and keloids develop in predisposed individuals following injury to the reticular dermis, including surgical incisions, burns, or trauma. In highly susceptible individuals, minor injuries, such as folliculitis or insect bites, may also lead to keloid formation. Multiple cell types, including fibroblasts, myofibroblasts, keratinocytes, melanocytes, mast cells, and endothelial cells, contribute to scarring. Endothelial dysfunction during inflammation increases vascular permeability, promoting prolonged inflammation and fibrosis. Pathologic scars involve elevated cytokines and growth factors, such as transforming growth factor beta, VEGF, platelet-derived growth factor, IL-6, and IL-8.
2
3
Epidemiology
Keloids and hypertrophic scars most commonly appear between ages 10 and 30 years. The epidemiology of keloids varies, with reported annual incidence ranging from 0.09% in England and 0.15% in Taiwan to as high as 4.5% and 16% in African and Hispanic populations. The incidence of hypertrophic scars is reported at 40-70% after surgery and over 90% after burns.
4
5
Risk factors
Inciting factors include various dermal injuries, especially surgery, trauma, and burns. Risk factors include genetic predisposition, family history, African, Hispanic, and Asian origin, young age (10-30 years), and pregnancy.
6
Disease course
Hypertrophic scars and keloids appear as firm, raised, erythematous lesions with a glossy surface, typically red in White individuals and purple to black in Black individuals. Keloids commonly form unique shapes, influenced by local tension forces. Hypertrophic scars typically grow for 3-6 months before stabilizing and regressing, particularly in patients with a lower risk of pathologic scarring. Pain and itching are prominent symptoms of keloids and are often more intense than in hypertrophic scars.
7
8

Guidelines

Key sources

The following summarized guidelines for the management of keloids and hypertrophic scars are prepared by our editorial team based on guidelines from the American Academy of Family Physicians (AAFP 2024,2009) and the German Society of General and Visceral Surgery (DGAV/DDG/BVDD/DGPRÄC/DGMKG/DGV/DGDC/DDL/DEGRO 2021).
1
2
3
4
5
6
7
8
9
10
11

Medical management

Topical 5-FU
As per BVDD/DDG/DDL/…/DGV 2021 guidelines:
Consider offering topical 5-FU for the treatment of otherwise refractory hypertrophic scars
C
and keloids.
C
Consider offering topical 5-FU for preventing de novo formation of hypertrophic scars or keloids in at-risk patients, and for preventing recurrence after surgical treatment.
C
Create free account

More topics in this section

  • Topical imiquimod

  • Topical corticosteroids

  • Topical CCBs

Nonpharmacologic interventions

Silicone gel sheeting
As per BVDD/DDG/DDL/…/DGV 2021 guidelines:
Consider offering silicone preparations especially as an add on in the treatment of active hypertrophic scars.
C
Consider offering postoperative silicone preparations for the preventiion of de novo formation of hypertrophic scars and keloids in predisposed/at-risk patients, and after surgical treatment of hypertrophic scars or keloids.
C

More topics in this section

  • Pressure therapy

  • Microneedling

  • Topical vitamin E

  • Topical onion extract

Therapeutic procedures

Cryotherapy: as per AAFP 2024 guidelines, offer multiple sessions of cryotherapy to promote keloid regression, with intralesional cryotherapy being more effective than spray cryotherapy.
B

More topics in this section

  • Intralesional corticosteroids

  • Intralesional onabotulinumtoxinA

  • Other intralesional agents

  • Laser therapy

  • Radiotherapy

Surgical interventions

Indications for surgery: as per BVDD/DDG/DDL/…/DGV 2021 guidelines, do not offer exclusively surgical treatment for keloids. Do not offer surgical treatment of hypertrophic scars without tensile stress or cosmetic disfigurement that have been present for < 1 year.
D
Show 6 more

Patient education

General counseling: as per AAFP 2024 guidelines, consider counseling patients with previous keloids and hypertrophic scars to avoid elective procedures.
C

Follow-up and surveillance

Management of inadequate response: as per BVDD/DDG/DDL/…/DGV 2021 guidelines, modify the treatment strategy (combination, switching, or increasing the dosage) if treatment success is not satisfactory after 3-6 sessions/3-6 months.
B